Chengdu Shengnuo Biopharm Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ZICONOTIDE ACETATE, with a corresponding US DMF Number 33139.
Remarkably, this DMF maintains an Active status since its submission on April 11, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 23, 2019, and payment made on June 18, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II